Your session is about to expire
← Back to Search
Behavioural Intervention
T2DXcel mobile application for Type 2 Diabetes (T2DXcel Trial)
Phase 1 & 2
Waitlist Available
Led By Sunit Jariwala, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights
T2DXcel Trial Summary
This study is evaluating whether a mobile application can help improve diabetes management.
T2DXcel Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline hemoglobin A1c to 3 and 6 months
Secondary outcome measures
Change from baseline LDL cholesterol to 3 months and 6 months
Change from baseline diabetes knowledge to 3 months and 6 months
Change from baseline diabetes quality of life to 3 months and 6 months
+3 moreT2DXcel Trial Design
1Treatment groups
Experimental Treatment
Group I: T2DXcel mobile applicationExperimental Treatment1 Intervention
T2DXcel is a mobile application (patient-facing) that delivers guideline-based diabetes education.
Find a Location
Who is running the clinical trial?
Montefiore Medical CenterLead Sponsor
442 Previous Clinical Trials
582,471 Total Patients Enrolled
Sunit Jariwala, MDPrincipal InvestigatorAlbert Einstein College of Medicine and Montefiore Medical Center
3 Previous Clinical Trials
167 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger